Group 1 - CITIC Construction Investment has received approval from the China Securities Regulatory Commission to issue perpetual subordinated bonds with a total face value of no more than 20 billion yuan [1] - Bluefocus Technology has received a loan commitment of up to 900 million yuan from CITIC Bank for stock repurchase [1] - Huaren Pharmaceutical's subsidiary has received approval for the listing of Bumetanide raw materials, which are used to treat severe heart failure and hypertension emergencies [3] Group 2 - Betta Pharmaceuticals has received approval for the listing of Enasidenib capsules in Macau, aimed at treating ALK-positive locally advanced or metastatic non-small cell lung cancer [4] - Juewei Food plans to use 110 million yuan of idle fundraising for cash management, with an expected annual yield of 1.00%-1.89% [6] - China Huadian has successfully completed the issuance of 1 billion yuan medium-term notes with a coupon rate of 1.95% [9] Group 3 - Fosun Pharma's subsidiary has received a GMP certificate from the Belgian Federal Agency for Medicines and Health Products for the production facilities of two monoclonal antibodies [11] - China Nuclear Engineering has signed a civil engineering contract for the Taishan Nuclear Power Units 3 and 4 [13] - Kanglongda has faced administrative regulatory measures from the Zhejiang Securities Regulatory Bureau due to the failure of performance commitment parties to fulfill compensation obligations [15] Group 4 - Gaoling Information has received three invention patent certificates in the second quarter, covering various technological fields [16] - Weimais plans to use 190 million yuan of excess fundraising to increase capital in its subsidiary for building a new energy vehicle powertrain production base [17] - Huazhong Technology has received a project designation notice from a leading eVTOL manufacturer for the development and supply of an intelligent cockpit multimedia display system [19] Group 5 - Madi Technology expects a net profit of 25 million to 27 million yuan for the first half of 2025, marking a turnaround from a loss in the previous year [19] - Dazhong Mining's subsidiary has obtained a mining license for the Zhouyoufang Iron Mine, increasing production capacity to 6.5 million tons per year [20] - Zhongguancun's subsidiary has had its application for the listing of Arolol hydrochloride tablets accepted by the National Medical Products Administration [21] Group 6 - Tianhong Co. has signed a property management contract worth 15 million yuan with a local company [22] - Dong'an Power has secured nine new market designation agreements in the second quarter, with a projected total sales volume of 1.5 million units [24] - Zhujiang Co. has appointed Zhao Kun as the new deputy general manager [25] Group 7 - Jinyi Industrial has won a bid for a project worth 335 million yuan from the China Railway Shanghai Bureau Group [26] - Kangchen Pharmaceutical has received a clinical trial notification for its innovative drug KC1086, aimed at treating advanced solid tumors [27] - Changhua Group has received a project designation notice from a new energy vehicle company, with an expected total sales amount of 970 million yuan [29] Group 8 - Lingxiao Pump Industry plans to use 60 million yuan of idle funds to purchase financial products [31] - Mould Technology has received a project designation for exterior parts from a well-known North American electric vehicle company, with an expected total sales of 1.236 billion yuan [34] - Fulongma has pre-bid for five sanitation service projects in June, with a total contract amount of 181 million yuan [35] Group 9 - Changchun High-tech plans to issue H-shares and list on the Hong Kong Stock Exchange [36] - *ST Yuancheng is under investigation by the CSRC for suspected false financial disclosures [37] - Beilu Pharmaceutical's subsidiary has received approval for the listing of Iopamidol raw materials [38] Group 10 - Zhejiang Liming's shareholder plans to reduce their stake by up to 2.93% [39] - Zhejiang Liming's actual controller has committed not to reduce their holdings within a year [40] - SAIC Motor reported a total vehicle sales of 2.0526 million units in the first half of 2025, a year-on-year increase of 12.35% [41] Group 11 - Xinhongcheng expects a net profit increase of 50%-70% for the first half of 2025 [42] - Xianhe Co. plans to invest 11 billion yuan in a bamboo pulp paper integrated project [42] - Great Wall Motors reported a total vehicle sales of 569,800 units in the first half of 2025, a year-on-year increase of 1.81% [43] Group 12 - Dongfeng Co. received a government subsidy of 10 million yuan [44] - Zhongke Environmental Protection has acquired two water environmental companies in Guangxi for a total of 353 million yuan [45] - Anji Food's H-share public offering is priced at 60 Hong Kong dollars per share [46]

股票代码：601002 股票简称：晋亿实业 公告编号：临2025-014号 晋亿实业股份有限公司 关于收到中标通知书的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 晋亿实业股份有限公司（以下简称"公司"）近日收到中国铁路上海局集团 有限公司南京铁路枢纽工程建设指挥部发来的《中标通知书》，确定公司为新建 南京至淮安城际铁路(招标编号: T0WZ202500400、物资类别/名称:高速铁路扣件、 包件号:F02) 材料采购招标的中标人，具体情况公告如下： 一、项目中标基本情况 三、 风险提示 截至本公告披露日，本次中标后相关合同的签署工作正在有序开展中，公司 尚未与招标人签署正式合同，能否顺利签署正式合同尚存在不确定性，项目总金 额、具体实施内容等以最终签署的正式合同为准。公司将按规定及时披露该项目 后续进展情况，敬请广大投资者谨慎决策，注意防范投资风险。 特此公告。 晋亿实业股份有限公司 董 事 会 1. 项目名称：新建南京至淮安城际铁路(招标编号: T0WZ202500400、物资 类别/名称:高速铁路扣件、包件 ...

Core Viewpoint - Jin Yi Industrial has won a bid for a project worth 335 million RMB, which is expected to positively impact the company's operating performance [1] Group 1 - The company received a "Notice of Winning Bid" from the Nanjing Railway Hub Engineering Construction Command of China Railway Shanghai Bureau Group [1] - The project involves the procurement of materials for the new Nanjing to Huai'an intercity railway [1] - The specific impact on the company's financial performance will depend on the details of the transaction [1]

Group 1 - The core point of the news is that Jin Yi Industrial (601002) has announced a cash dividend of 0.1 yuan per share, with the record date set for June 4, 2025, and the payment date on June 5, 2025 [1][2] - As of May 30, 2025, Jin Yi Industrial's stock price closed at 4.89 yuan, reflecting a 0.41% increase from the previous week [1] - The company reached a market capitalization of 4.667 billion yuan, ranking 101 out of 215 in the general equipment sector and 3058 out of 5146 in the A-share market [1] Group 2 - The total cash dividend to be distributed amounts to 95,444,072 yuan [2] - For individual shareholders holding shares for over one year, the dividend income is exempt from personal income tax, resulting in a net distribution of 0.1 yuan per share [2] - For QFII shareholders and investors from the Hong Kong Stock Exchange, a 10% tax will be deducted, leading to a net dividend of 0.09 yuan per share [2]

Core Points - The company announced a cash dividend of 0.1 yuan per share for its A shares, totaling 95,444,072 yuan based on a total share capital of 954,440,720 shares [1][3] - The dividend distribution plan was approved at the annual shareholders' meeting held on April 15, 2025 [1][6] - Key dates for the dividend distribution include the record date on June 4, 2025, and the ex-dividend date on June 5, 2025 [1][2] Dividend Distribution Details - The cash dividend will be distributed to all shareholders registered with the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the record date [1][3] - For individual shareholders holding shares for more than one year, the dividend income is exempt from personal income tax, resulting in an actual cash dividend of 0.1 yuan per share [3][4] - For qualified foreign institutional investors (QFII), a 10% corporate income tax will be withheld, leading to an actual cash dividend of 0.09 yuan per share [4][5] Taxation Information - Individual shareholders holding shares for less than one month will incur a 20% tax on dividend income, while those holding for one month to one year will incur a 10% tax [3][4] - The company will not withhold corporate income tax for other institutional investors and corporate shareholders, who will receive a cash dividend of 0.1 yuan per share [5][6]

证券代码：601002 证券简称：晋亿实业 公告编号：2025-013 晋亿实业股份有限公司2024年年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 每股分配比例 A 股每股现金红利0.1元 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/6/4 | － | 2025/6/5 | 2025/6/5 | 差异化分红送转： 否 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经公司2025 年 4 月 15 日的2024年年度股东大会审议通过。 二、 分配方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公司上海分 公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 本次利润分配以方案实施前的公司总股本954,440,720股为基数，每股派发现金红利0.1 元（含税），共计派发现金红利95,444,072元。 1. ...

Core Viewpoint - The announcement emphasizes the commitment of the board and management of Jin Yi Industrial Co., Ltd. to ensure the authenticity, accuracy, and completeness of the quarterly report, taking legal responsibility for any misrepresentation or omissions [1][2]. Financial Data Summary - The quarterly financial statements for the first quarter of 2025 are not audited [3]. - The report includes major accounting data and financial indicators, but specific figures are not provided in the text [3]. - Non-recurring gains and losses are applicable, but details on significant items are not specified [3]. - Changes in major accounting data and financial indicators are applicable, but specific reasons for changes are not detailed [4]. Shareholder Information - Information regarding the total number of common shareholders and the top ten shareholders is applicable, but specific data is not provided [4]. - There are no changes reported for major shareholders or the top ten unrestricted circulating shareholders due to securities lending activities [5]. Other Important Information - There are no additional reminders or important information regarding the company's operational situation during the reporting period [5]. - The financial statements, including the consolidated balance sheet and profit and cash flow statements for the first quarter of 2025, are prepared but not audited [6].

Financial Performance - The company's operating revenue for Q1 2025 was CNY 576,299,454.62, representing a 35.90% increase compared to CNY 424,066,092.18 in the same period last year[5] - Net profit attributable to shareholders was CNY 57,557,285.29, a significant recovery from a loss of CNY 20,608,945.66 in the previous year[5] - Basic and diluted earnings per share were both CNY 0.06, compared to a loss of CNY 0.022 per share in the same period last year[5] - The company reported a significant increase in net profit due to improved sales performance in its main business operations[8] - Total operating revenue for Q1 2025 reached ¥576,299,454.62, a 36% increase from ¥424,066,092.18 in Q1 2024[18] - Net profit for Q1 2025 was ¥57,892,928.83, a significant recovery from a net loss of ¥20,185,500.22 in Q1 2024[19] - Earnings per share for Q1 2025 were ¥0.06, compared to a loss per share of ¥0.022 in Q1 2024[20] - The total comprehensive income for Q1 2025 was ¥57,923,408.83, recovering from a loss of ¥20,202,426.60 in Q1 2024[19] Cash Flow and Investments - The net cash flow from operating activities decreased by 94.87%, amounting to CNY 6,735,144.70, down from CNY 131,229,445.18 in the previous year[5] - Cash flow from operating activities for Q1 2025 was ¥6,735,144.70, down from ¥131,229,445.18 in Q1 2024[21] - Net cash flow from investment activities was -$77.01 million, a significant decrease from -$4.93 million in the previous period[22] - Total cash inflow from investment activities was $132.26 million, compared to $314.61 million last year, indicating a decline of approximately 58%[22] - Total cash outflow from investment activities reached $209.28 million, down from $319.54 million, reflecting a decrease of about 35%[22] - Cash flow from financing activities resulted in a net outflow of -$57,557.49, compared to -$51.46 million in the previous period[22] - The net increase in cash and cash equivalents was -$70.93 million, compared to an increase of $75.26 million in the previous period[22] - The ending balance of cash and cash equivalents was $455.64 million, down from $229.42 million last year[22] Assets and Liabilities - Total assets at the end of the reporting period were CNY 5,174,997,793.79, a slight decrease of 0.12% from CNY 5,181,470,875.50 at the end of the previous year[6] - Total current assets as of March 31, 2025, amount to ¥3,219,706,614.64, a slight increase from ¥3,201,522,687.77 on December 31, 2024[14] - Total liabilities decreased to ¥931,133,863.61 from ¥996,426,606.69, indicating a reduction of approximately 6.5%[15] - The company's total assets as of March 31, 2025, are ¥5,174,997,793.79, slightly down from ¥5,181,470,875.50[14] - The non-current assets total is ¥1,955,291,179.15, down from ¥1,979,948,187.73, reflecting a decrease of about 1.2%[14] - The company reported a decrease in short-term borrowings, contributing to the overall reduction in liabilities[15] Shareholder Information - The largest shareholder, CHIN CHAMP ENTERPRISE CO., LTD., holds 372,064,367 shares, representing 38.98% of total shares[11] - Shareholders' equity attributable to the parent company increased by 1.40%, reaching CNY 4,233,569,471.29 compared to CNY 4,175,085,453.46 at the end of the previous year[6] - The company’s total equity increased to ¥4,243,863,930.18 from ¥4,185,044,268.81 year-over-year[16] Operational Insights - The increase in operating revenue was primarily driven by higher sales of railway fastening system products during the reporting period[8] - Research and development expenses increased to ¥24,376,825.15 in Q1 2025, up from ¥15,882,757.56 in Q1 2024, marking a 53.5% rise[18] - The company has not reported any changes in major shareholders or significant operational issues during the reporting period[12] Accounting Changes - The company plans to implement new accounting standards starting in 2025, which may affect the financial statements[23]

Group 1 - The company Jin Yi Industrial (601002) reported a revenue of 576 million yuan in the first quarter of 2025, representing a year-on-year increase of 35.90% [1] - The net profit for the same period was 57.56 million yuan, a significant turnaround from a net loss of 20.61 million yuan in the previous year [1]

Core Insights - As of April 21, 2024, 2,246 companies have released their annual reports, with 1,197 reporting a year-on-year increase in net profit, while 1,049 reported a decline [1] - A total of 1,341 companies saw an increase in operating revenue, whereas 904 experienced a decrease [1] - Companies that reported simultaneous growth in both net profit and operating revenue include 940 firms, while 648 companies saw declines in both metrics [1] - Notably, 234 companies achieved a net profit growth rate exceeding 100%, with Zhengdan Co., Ltd. leading at an impressive 11,949.39% increase [1] Company Performance Summary - Zhengdan Co., Ltd. (300641) reported earnings per share of 2.35 yuan, with a net profit of 1,189.89 million yuan, reflecting a year-on-year increase of 11,949.39%, and operating revenue of 348.02 million yuan, up 126.31% [1] - Guangxi Energy (600310) reported earnings per share of 0.043 yuan, with a net profit of 62.99 million yuan, a significant increase of 3,704.04%, but a decline in operating revenue by 76.48% to 393.16 million yuan [1] - Siwei (688213) achieved earnings per share of 0.98 yuan, with a net profit of 39.27 million yuan, marking a 2,662.76% increase, and operating revenue of 596.81 million yuan, up 108.87% [1] - Other notable performers include Andis (600299) with a net profit of 120.43 million yuan (up 2,208.66%) and operating revenue of 1,553.43 million yuan (up 17.83%) [1] - Companies like Huabei Pharmaceutical (600812) and Jiangsu Suo (600746) also reported significant changes in their financial metrics, with varying trends in net profit and operating revenue [1][2]